ArticleOncotarget2016

LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling.

Yuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.